Pharmagen, Inc. (PHRX)

USD 0.0

(0.0%)

EBITDA Summary of Pharmagen, Inc.

  • Pharmagen, Inc.'s latest annual EBITDA in 2013 was -2.89 Million USD , down 0.0% from previous year.
  • Pharmagen, Inc.'s latest quarterly EBITDA in 2014 Q1 was -380.37 USD , up 48.76% from previous quarter.
  • Pharmagen, Inc. reported a quarterly EBITDA of N/A for 2013 FY, down 0.0% from previous quarter.
  • Pharmagen, Inc. reported a quarterly EBITDA of -742.27 USD for 2013 Q4, down -8.12% from previous quarter.

Annual EBITDA Chart of Pharmagen, Inc. (2013 - 2013)

Historical Annual EBITDA of Pharmagen, Inc. (2013 - 2013)

Year EBITDA EBITDA Growth
2013 -2.89 Million USD 0.0%

Peer EBITDA Comparison of Pharmagen, Inc.

Name EBITDA EBITDA Difference
China Medicine Corporation 13.27 Million USD 121.791%
DH Enchantment Inc. -145.23 Thousand USD -1892.402%
Exlites Holdings International, Inc. -90.49 Thousand USD -3097.558%
Itonis, Inc. -38.31 Thousand USD -7453.031%
One Step Vending Corp. -26.55 Thousand USD -10797.733%
MediPal Holdings Corporation 431.52 Million USD 100.671%
PD-Rx Pharmaceuticals, Inc. -51.41 Thousand USD -5527.426%
Suzuken Co., Ltd. 340.78 Million USD 100.849%